Contact this trialFirst, we need to learn more about you.
Bruton's Tyrosine Kinase Inhibitor
Pirtobrutinib for Immune Thrombocytopenic Purpura
Recruiting0 awardsPhase 1 & 2
Washington, District of Columbia
"This trial aims to see how well pirtobrutinib is tolerated and what side effects may occur in patients with Primary Immune Thrombocytopenia. It will also investigate the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service